Man Group PLC Blueprint Medicines Corp Transaction History
Man Group PLC
- $38.1 Billion
- Q1 2024
A detailed history of Man Group PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Man Group PLC holds 408,880 shares of BPMC stock, worth $43.2 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
408,880
Previous 378,064
8.15%
Holding current value
$43.2 Million
Previous $34.9 Million
11.22%
% of portfolio
0.1%
Previous 0.1%
Shares
21 transactions
Others Institutions Holding BPMC
# of Institutions
314Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$681 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$666 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$660 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$441 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$264 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.3B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...